Results 241 to 250 of about 8,631,498 (387)

Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the utility of smartwatch and smartphone‐based activity metrics for assessing disease severity and quality of life in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Methods In the electronic monitoring of disease activity in patients with CIDP (EMDA‐CIDP) trial, we performed a prospective ...
Lars Masanneck, Jan Voth, Noëmi Gmahl, Konstantin Jendretzky, Niklas Huntemann, Noah M. Werner, Linea Schmidt, Menekse Oeztuerk, Paula Quint, Christina B. Schroeter, Hans Peter Hartung, Thomas Skripuletz, Gerd Meyer zu Hörste, Tobias Ruck, Sven G. Meuth, Marc Pawlitzki   +15 more
wiley   +1 more source

Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data. [PDF]

Front Pharmacol
Hu Y, Miao P, Chen S, Mao F, Wang S, Feng J, Chen J, Yu L, Dai H.   +8 more
europepmc   +1 more source

Vancomycin Therapeutic Drug Monitoring in Newborn Infants with Sepsis : Clinical Effectiveness and Concentration Relationships 1458 [PDF]

, 1998
José Kleber Kobol Machado, Rubens Feferbaum, Edna MA Diniz, F. A. C. Vaz   +3 more
openalex   +1 more source

Methylxanthine Drug Monitoring with Wearable Sweat Sensors

Advances in Materials, 2018
Li-Chia Tai, W. Gao, Minghan Chao, Mallika Bariya, Q. P. Ngo, Ziba Shahpar, H. Nyein, Hyejin Park, Junfeng Sun, You-Kyung Jung, E. Wu, H. Fahad, D. Lien, H. Ota, Gyoujin Cho, A. Javey   +15 more
semanticscholar   +1 more source

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li   +8 more
wiley   +1 more source

Long-term efficacy of therapeutic drug monitoring-guided optimization of ustekinumab maintenance therapy for Crohn's disease patients. [PDF]

Sci Rep
Ren H, Su J, Yin A, Gao X, Wang W, Li J, Kang J, Wang J, Zhou Q, An J, Tang Z, Wang X, Wan H, Chen W, Wu P, An P.   +15 more
europepmc   +1 more source

Analysis of an 8-years interval of the Japanese Ministry of Health and Welfare's "Adverse Drug Reaction Monitoring" database.

, 1990
Ryoko Aso, Hiroko Hara, Fumie Takahashi, Kazushi OHASHI   +3 more
openalex   +2 more sources

Colchicine Concentrations and Relationship With Colchicine Efficacy and Adverse Events: Post Hoc Analysis of a Randomized Clinical Trial of Colchicine for Gout Flare Prophylaxis

Arthritis Care &Research, EarlyView.
Objective Our objective was to examine the relationship between colchicine plasma concentrations and clinical and demographic factors and to determine the relationship between colchicine concentrations and colchicine efficacy and colchicine‐specific adverse events.
Lisa K. Stamp, Anne Horne, Borislav Mihov, Jill Drake, Janine Haslett, Peter Chapman, Daniel F. B. Wright, Christopher Frampton, Nicola Dalbeth   +8 more
wiley   +1 more source

Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: "early therapeutic drug monitoring of adalimumab". [PDF]

Clin Rheumatol
Ortiz-Fernández P, Iniesta-Navalón C, Urbieta-Sanz E, Gascón-Cánovas JJ.   +3 more
europepmc   +1 more source

Progressive Trial on Clinical Pharmacy Services in a Hospital (II). Therapeutic Drug Monitoring of Methotrexate during the High Dose Methotrexate Therpy.

, 1994
Norifumi Morikawa, Kenji Kumagai, Masaharu Takeyama   +2 more
openalex   +2 more sources